Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: a systematic review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: a systematic review
Authors
Keywords
Psychedelics, Psilocybin, Ayahuasca, Psychiatric disorders, Addictive disorders
Journal
JOURNAL OF PSYCHIATRIC RESEARCH
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-03-07
DOI
10.1016/j.jpsychires.2021.03.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression
- (2020) Lea J Mertens et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
- (2020) Gabrielle I Agin-Liebes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey
- (2020) Albert Garcia-Romeu et al. Frontiers in Psychiatry
- Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
- (2019) Martin K. Madsen et al. NEUROPSYCHOPHARMACOLOGY
- Cessation and reduction in alcohol consumption and misuse after psychedelic use
- (2019) Albert Garcia-Romeu et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Replication and extension of a model predicting response to psilocybin
- (2019) Suzanne L. Russ et al. PSYCHOPHARMACOLOGY
- Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects
- (2019) Lukasz Smigielski et al. NEUROIMAGE
- Effects of psilocybin therapy on personality structure
- (2018) D. Erritzoe et al. ACTA PSYCHIATRICA SCANDINAVICA
- Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression
- (2018) Facundo Carrillo et al. JOURNAL OF AFFECTIVE DISORDERS
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
- (2018) Fernanda Palhano-Fontes et al. PSYCHOLOGICAL MEDICINE
- Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
- (2018) Deborah S. Hasin et al. JAMA Psychiatry
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
- (2018) Leor Roseman et al. Frontiers in Pharmacology
- Emotional blunting with antidepressant treatments: A survey among depressed patients
- (2017) G.M. Goodwin et al. JOURNAL OF AFFECTIVE DISORDERS
- An online survey of tobacco smoking cessation associated with naturalistic psychedelic use
- (2017) Matthew W Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Serotonin and brain function: a tale of two receptors
- (2017) RL Carhart-Harris et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
- (2017) Leor Roseman et al. NEUROPHARMACOLOGY
- Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression
- (2017) J. B. Stroud et al. PSYCHOPHARMACOLOGY
- Psychedelics and connectedness
- (2017) R. L. Carhart-Harris et al. PSYCHOPHARMACOLOGY
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
- (2017) R. L. Carhart-Harris et al. PSYCHOPHARMACOLOGY
- Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects
- (2017) F Mueller et al. Translational Psychiatry
- Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
- (2017) Robin L Carhart-Harris et al. Scientific Reports
- Psychedelics as Medicines: An Emerging New Paradigm
- (2016) DE Nichols et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
- (2016) Patrick C Dolder et al. NEUROPSYCHOPHARMACOLOGY
- Effects of serotonin 2A/1A receptor stimulation on social exclusion processing
- (2016) Katrin H. Preller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-term follow-up of psilocybin-facilitated smoking cessation
- (2016) Matthew W. Johnson et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity
- (2016) Rainer Kraehenmann et al. NeuroImage-Clinical
- Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
- (2015) Adam L. Halberstadt BEHAVIOURAL BRAIN RESEARCH
- Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats
- (2015) Yuichi Sakashita et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis
- (2015) Harry Man Xiong Lai et al. DRUG AND ALCOHOL DEPENDENCE
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
- (2015) Michael P Bogenschutz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Epidemiology ofDSM-5Alcohol Use Disorder
- (2015) Bridget F. Grant et al. JAMA Psychiatry
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
- (2014) Matthew W Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors
- (2012) Michael Kometer et al. BIOLOGICAL PSYCHIATRY
- Family history of alcohol dependence and antidepressant response to anN-methyl-D-aspartate antagonist in bipolar depression
- (2012) David A Luckenbaugh et al. BIPOLAR DISORDERS
- Shaping the renaissance of psychedelic research
- (2012) Ben Sessa LANCET
- Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
- (2011) Katherine A MacLean et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Serotonin Receptor Expression in Human Prefrontal Cortex: Balancing Excitation and Inhibition across Postnatal Development
- (2011) Evelyn K. Lambe et al. PLoS One
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
- Enhanced Function of Prefrontal Serotonin 5-HT2 Receptors in a Rat Model of Psychiatric Vulnerability
- (2010) M. Benekareddy et al. JOURNAL OF NEUROSCIENCE
- The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
- (2010) Franz X. Vollenweider et al. NATURE REVIEWS NEUROSCIENCE
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2009) Alessandro Liberati et al. PLOS MEDICINE
- Family History of Alcohol Dependence and Initial Antidepressant Response to an N -methyl-D-aspartate Antagonist
- (2008) Laura E. Phelps et al. BIOLOGICAL PSYCHIATRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now